title: Portacaval anastomosis causes selective alterations of peripheral-type benzodiazepine receptor expression in rat brain and peripheral tissues.
abstract: There is a growing body of evidence to suggest that peripheral-type benzodiazepine receptors (PTBRs) and their endogenous ligands are implicated in the pathogenesis of end-organ failure in chronic liver disease. Portal-systemic encephalopathy, a major neuropsychiatric complication associated with chronic liver disease, results in activation of brain PTBR and probably in peripheral organs. In order to address these issues, PTBR mRNA was measured using semi-quantitative RT-PCR in extracts of cerebral cortex, kidney and testis of rats four weeks after end-to-side portacaval anastomosis and sham-operation (controls). Densities of PTBR sites were measured concomitantly by in vitro receptor binding using the selective PTBR ligand [3H]PK11195. Portacaval shunting resulted in a 2 to 3-fold increase in expression of PTBR in brain and kidney and a 37% reduction in expression in testis. Densities of [3H]PK11195 sites changed in parallel with the alterations of gene expression. These findings suggest that selective alterations of PTBR expression are implicated in the pathogenesis of peripheral tissue hypertrophy (kidney) and/or atrophy (testis) which accompanies portal-systemic shunting in chronic liver failure. In brain, activation of PTBR could result in an increase in the production of neurosteroids with potent inhibitory action in the CNS, which could contribute to the pathogenesis of portal-systemic encephalopathy.
authors.affiliation: Neuroscience Research Unit, CHUM (Campus Saint-Luc), Montreal, Quebec, Canada. butterw@ere.umontreal.ca
authors.forename: P
authors.initials: P
authors.lastname: Desjardins
authors.forename: P
authors.initials: P
authors.lastname: Bandeira
authors.forename: V L
authors.initials: VL
authors.lastname: Rao
authors.forename: R F
authors.initials: RF
authors.lastname: Butterworth
mesh_terms: D000818:Animals; D001483:Base Sequence; D002540:Cerebral Cortex / Q000378:metabolism*; D017931:DNA Primers; D015870:Gene Expression; D007546:Isoquinolines / Q000378:metabolism; D007668:Kidney / Q000378:metabolism*; D008297:Male; D011167:Portacaval Shunt, Surgical; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011963:Receptors, GABA-A / Q000235:genetics* / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013737:Testis / Q000378:metabolism*
chemical_list: D017931:DNA Primers; D007546:Isoquinolines; D012333:RNA, Messenger; D011963:Receptors, GABA-A; C037850:PK 11195